Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Airline Industry Today.
Press releases published on July 21, 2025
CEMATRIX Announces $5.1 Million in New Contract Awards
GlobeNewswire
·
July 21, 2025
CALGARY, Alberta, July 21, 2025 (GLOBE NEWSWIRE) -- CEMATRIX Corporation (TSX: CEMX) (OTCQB: CTXXF) ("CEMATRIX" or the "Company"), a specialty construction contractor that produces cellular concrete solutions on site and is a leading manufacturer and …
ZyVersa Therapeutics CEO Issues Mid-year Shareholder Letter Highlighting Recent Corporate Developments and R&D Progress
GlobeNewswire
·
July 21, 2025
WESTON, Fla., July 21, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who …
Amneal Announces Proposed Refinancing of Existing Credit Agreement, including Private Offering of Senior Secured Notes Due 2032
GlobeNewswire
·
July 21, 2025
BRIDGEWATER, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal”) (Nasdaq: AMRX) announced that its subsidiary, Amneal Pharmaceuticals LLC (the “Issuer”), is seeking to borrow $1.800 billion aggregate principal amount of new …
Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results
GlobeNewswire
·
July 21, 2025
– Results Reflect Continued Financial Strength and Deleveraging – BRIDGEWATER, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced certain unaudited preliminary financial results …
Cognition Therapeutics Publishes Proteomic Analysis Elucidating Zervimesine’s Protection of Neurons and Synapses in Alzheimer’s Disease
GlobeNewswire
·
July 21, 2025
PITTSBURGH, July 21, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, published results of a proteomics analysis from the …
Q-Gold Resources engages FHB Consulting Services LLC to update the Resource Estimate for Quartz Mountain
GlobeNewswire
·
July 21, 2025
TORONTO, July 21, 2025 (GLOBE NEWSWIRE) -- Q-Gold Resources Ltd. (TSXV: QGR) (“Q-Gold” or the “Company”) is pleased to announce that it has retained FHB Consulting Services LLC (“FSB Consulting”), a Washington-based geological consulting firm that is …
Nasdaq Verafin Announces Launch of its Agentic AI Workforce, Delivering a Step Change in AML Compliance Efficiency
GlobeNewswire
·
July 21, 2025
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Nasdaq Verafin today announced the launch of the Agentic AI Workforce, a suite of digital workers that will deliver a step change in the way banks conduct anti-money laundering (AML) compliance by automating low- …
Stallion Uranium Refines Coyote Target with Highly Conductive Anomalies from Ground EM Survey
GlobeNewswire
·
July 21, 2025
VANCOUVER, British Columbia, July 21, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce the results from a Stepwise Moving Loop, Time Domain Electromagnetic (“SWML- …
Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in Conjunction with its 30th Anniversary
GlobeNewswire
·
July 21, 2025
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – today announced it intends to invest an …
Proposed Consolidation of Shares
GlobeNewswire
·
July 21, 2025
Vancouver, British Columbia, July 21, 2025 (GLOBE NEWSWIRE) -- First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (the “Company”) announces that the Company intends to consolidate the common shares in the capital of the Company (the “Shares”) …
Domestic Metals Begins Trading on OTCQB
GlobeNewswire
·
July 21, 2025
VANCOUVER, British Columbia, July 21, 2025 (GLOBE NEWSWIRE) -- Domestic Metals Corp. (the “Company” or “Domestic”) - (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E) announces that its common shares have started trading on the OTCQB marketplace, a U.S. marketplace …
Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline
GlobeNewswire
·
July 21, 2025
Comprehensive review of broad pipeline targeting Alzheimer’s disease agitation, depression, narcolepsy, fibromyalgia, ADHD, and smoking cessation, with new data analyses Presentations by expert clinicians and key opinion leaders Company to webcast its R…
NextGen Digital Announces Treasury Strategy to Incorporate Crypto Assets, Acquires $1.0 Million in Bitcoin
GlobeNewswire
·
July 21, 2025
Vancouver, B.C., July 21, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform focused on bridging traditional capital markets with Web3 infrastructure, …
SAB BIO Announces Oversubscribed $175 Million Private Placement
GlobeNewswire
·
July 21, 2025
Participation from strategic investor Sanofi, along with new investors RA Capital Management, Commodore Capital, Vivo Capital, Blackstone Multi-Asset Investing, Spruce Street Capital, Forge Life Science Partners and Woodline Partners LP, and existing …
Ocugen, Inc. Announces New Appointments to Retina Scientific Advisory Board & Executive Leadership Team
GlobeNewswire
·
July 21, 2025
MALVERN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced updates to its Retina Scientific Advisory Board (SAB) and …
Ambiq Announces Launch of Initial Public Offering
GlobeNewswire
·
July 21, 2025
Ambiq Announces Launch of Initial Public Offering AUSTIN, Texas, July 21, 2025 (GLOBE NEWSWIRE) -- Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the commencement of its initial …
iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right
GlobeNewswire
·
July 21, 2025
WATERTOWN, Mass. and GOSSELIES, Belgium, July 21, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (“iTeos”) (Nasdaq: ITOS) today announced that it has entered into a definitive merger agreement whereby Concentra Biosciences, LLC (“Concentra”) will …
Digi Power X Announces $15 Million Registered Direct Offering of Common Stock
GlobeNewswire
·
July 21, 2025
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. The offering was to a single new fundamental institutional …
TidyCoin Launches to Turn Crypto Clutter Into Deflationary Gold With a First-of-Its-Kind Burn Ecosystem
GlobeNewswire
·
July 21, 2025
GEORGE TOWN, Cayman Islands, July 21, 2025 (GLOBE NEWSWIRE) -- TidyCoin (keep scrolling for the $TIDY contract address), an innovative new entrant in the crypto space, has officially launched with a mission to clean up the digital chaos cluttering user …
ImCheck’s Announces EMA Orphan Drug Designation for ICT01 as Treatment for Acute Myeloid Leukemia
GlobeNewswire
·
July 21, 2025
ImCheck’s Announces EMA Orphan Drug Designation for ICT01 as Treatment for Acute Myeloid Leukemia Following the FDA ODD, European designation underscores ICT01’s potential as a novel immunotherapy approach in AML Marseille, France, July 21, 2025 – ImCheck …